A Phase II Study of TollB-001 Tablets in Systemic Sclerosis

NCT07745725 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Systemic Sclerosis (SSc)

Interventions

DRUG: TollB-001 Tablet
DRUG: Placebo

Sponsor

Toll Biotech Co. Ltd. (Beijing)